WHAT THIS PROGRAM SUPPORTS
Provider-guided weight management support built around long-term results.
Structured cash-pay programs that may include GLP-1-based treatment support, provider oversight, lab review, and ongoing monitoring when clinically appropriate.
Treatment is not guaranteed. Prescriptions are issued only when clinically appropriate.
Weight Management Support
Weight Management
Appetite Regulation
Intake
HOW IT WORKS
Provider Review
Complete a detailed intake about your health, symptoms, and goals.
Metabolic Health
Active Lifestyle Goals
Long-Term Accountability
SEMAGLUTIDE
Price includes all doses, supplies and cold shipping.
A licensed provider reviews your information and determines next steps.
Pharmacy Coordination
If appropriate, your treatment is coordinated through a licensed compounding pharmacy.
MONTHLY
$349
Best for patients who want to try it before they commit
3-MONTH PROGRAM
6-MONTH PROGRAM
$972
Save $75 compared to monthly billing
Effective monthly price: $324/month
$1,794
Save $300 compared to monthly billing
Effective monthly price: $299/month
TIRZEPATIDE
Ongoing Support
We monitor progress and make adjustments to help you reach your goals.
MONTHLY
$499
Best for patients who want to try it before they commit
3-MONTH PROGRAM
6-MONTH PROGRAM
$1,422
Save $75 compared to monthly billing
Effective monthly price: $474/month
$2,694
Save $300 compared to monthly billing
Effective monthly price: $449/month
Price includes all doses, supplies and cold shipping.
Provider evaluation
Adults with weight loss goals
Individuals seeking appetite and portion control support
GLP-1 receptor agonist support that may help with appetite regulation, weight management, and metabolic health when clinically appropriate.
Patients looking for long-term lifestyle and health improvements
Intake and eligibility review
Lab review when appropriate
Provider-guided planning
Pharmacy coordination
-
Semaglutide and tirzepatide are both once weekly injectable medications commonly considered in provider-guided weight management programs, but they work slightly differently in the body. Semaglutide primarily targets the GLP-1 pathway involved in appetite regulation and metabolic support, while tirzepatide targets both GLP-1 and GIP pathways. Providers determine the most appropriate option based on individual goals, medical history, and treatment response.
-
Focusing on appetite regulation, portion control, metabolic health, and long-term wellness goals we work together to determine the appropriate amount of calories, protein, water physical activity and medication dosage (if applicable) with the intention of lifestyle modification and getting of any medication as quickly as possible.
This once weekly injection is to be used as a tool to reach your goals as opposed to something to rely on long-term.
-
In some cases, providers may require baseline or follow-up lab work depending on medical history, treatment goals, current medications, and ongoing monitoring needs.
-
Some compound formulations may include pyridoxine, methylcobalamin, glycine, carnitine or other vitamins as part of a broader wellness-focused treatment approach. Providers will consider these formulations based on patient-specific goals, treatment tolerability considerations and pharmacy availability.
-
Results vary from patient to patient. Some individuals may begin noticing appetite-related changes or weight management support within the first several weeks, while longer-term wellness and body composition goals typically develop gradually over time alongside lifestyle consistency and provider-guided monitoring.
-
Some patients may experience gastrointestinal-related side effects such as nausea, fullness, bloating, constipation, or appetite changes. Providers review medical history, treatment tolerance, and ongoing response throughout care to help support safe and appropriate treatment planning.
-
Yes. Long-term wellness and weight management outcomes are typically best supported through a combination of provider-guided treatment, nutrition, movement, recovery, and sustainable lifestyle habits. This is the key to true long-lasting change.
Providers evaluate medical history, contraindications, medication interactions, and patient-specific goals before determining whether treatment is appropriate.
Continued adjusting and optimizing
SAFETY & MONITORING
Built around safety and oversight.
WHO THIS IS FOR
SEMAGLUTIDE
Those seeking provider-guided, medically supervised support
AVAILABLE SUPPORT OPTIONS
VS
PROGRAM FEATURES
Targets GLP-1 pathway
Supports appetite regulation and hunger control
May support gradual, steady weight management
Dual GIP + GLP-1 receptor agonist support that may help with appetite regulation, metabolic function, and weight management when clinically appropriate.
TIRZEPATIDE
Supports appetite regulation and satiety
Supports greater weight loss potential for some patients
Targets GIP and GLP-1 pathway
Start your weight management journey with confidence.
Personalized support. Provider oversight. Real results.